Inventor
ANDERSON DARRELL R
US22 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSON DARRELL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN IDEC INC
14 patentsUS7422739B2Sep 9, 2008
Anti-CD20 antibodies
BIOGEN IDEC INC166 citations99
US7381560B2Jun 3, 2008
Expression and use of anti-CD20 antibodies
BIOGEN IDEC INC45 citations96
US7192585B2Mar 20, 2007
CD80 specific antibodies
BIOGEN IDEC INC17 citations93
US7175847B1Feb 13, 2007
Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80 binding to CTLA-4
BIOGEN IDEC INC13 citations93
US7153508B2Dec 26, 2006
Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4
BIOGEN IDEC INC19 citations93
US7744877B2Jun 29, 2010
Expression and use of anti-CD20 Antibodies
BIOGEN IDEC INC38 citations92
US7510712B2Mar 31, 2009
Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies
BIOGEN IDEC INC5 citations74
US7491393B2Feb 17, 2009
Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies
BIOGEN IDEC INC4 citations74
US7425447B2Sep 16, 2008
Host cells expressing 7C10 and 16C10 CD80-specific antibodies
BIOGEN IDEC INC5 citations74
US7417128B2Aug 26, 2008
7C10 and 16C10 CD80-specific antibodies
BIOGEN IDEC INC5 citations74
US7323170B2Jan 29, 2008
Anti-CD80 antibodies
BIOGEN IDEC INC4 citations73
US7510713B2Mar 31, 2009
Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodies
BIOGEN IDEC INC1 citations63
US7501264B2Mar 10, 2009
Methods of producing 7C10 and 16C10 CD80-specific antibodies
BIOGEN IDEC INC1 citations63
US7414123B2Aug 19, 2008
Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
BIOGEN IDEC INC1 citations63
IDEC PHARMA CORP
5 patentsUS6682734B1Jan 27, 2004
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
IDEC PHARMA CORP176 citations99
US6399061B1Jun 4, 2002
Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma
IDEC PHARMA CORP254 citations99
US5776456AJul 7, 1998
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
IDEC PHARMA CORP527 citations99
US5736137AApr 7, 1998
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
IDEC PHARMA CORP1,577 citations99
US6113898ASep 5, 2000
Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
IDEC PHARMA CORP207 citations98
(unassigned)
3 patentsUS5843439ADec 1, 1998
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
336 citations98
US6893638B2May 17, 2005
Methods for treating b cell lymphoma using CD80-specific antibodies
40 citations94
US6709654B1Mar 23, 2004
Treatment of psoriasis using anti-B7.1 (CD80) antibodies
28 citations91